Development of a nanoparticle-based tendon-targeting drug delivery system to pharmacologically modulate tendon healing
Science Advances · 2024
DOI: 10.1126/sciadv.adn2332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Emmanuela Adjei-Sowah und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Rochester, Rochester, NY 14623, USA. Hauptthemen laut MEDLINE: Wound Healing, Tendon Injuries, Tendons. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIAMS NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Satisfactory healing following acute tendon injury is marred by fibrosis. Despite the high frequency of tendon injuries and poor outcomes, there are no pharmacological therapies in use to enhance the healing process. Moreover, systemic treatments demonstrate poor tendon homing, limiting the beneficial effects of potential tendon therapeutics. To address this unmet need, we leveraged our existing tendon healing spatial transcriptomics dataset and identified an area enriched for expression of Acp5 (TRAP) and subsequently demonstrated robust TRAP activity in the healing tendon. This unexpected finding allowed us to refine and apply our existing TRAP binding peptide (TBP) functionalized nanoparticle (NP) drug delivery system (DDS) to facilitate improved delivery of systemic treatments to the healing tendon. To demonstrate the translational potential of this DDS, we delivered niclosamide (NEN), an S100a4 inhibitor. While systemic delivery of free NEN did not alter healing, TBP-NP NEN enhanced both functional and mechanical recovery, demonstrating the translational potential of this approach to enhance the tendon healing process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of Rochester, Rochester, NY 14623, USA.
- Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY 14642, USA.
- Department of Chemical Engineering, University of Rochester, Rochester, NY 14623, USA.
- Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
- Department of Orthopaedics and Physical Performance, University of Rochester Medical Center, Rochester, NY 14642, USA.
ORCID-Profile: Emmanuela Adjei-Sowah, Jessica E Ackerman, Celia Soto, Anne E C Nichols, Danielle S W Benoit, Alayna E Loiselle
Förderung
- NCATS NIH HHS
- NIAMS NIH HHS
- NCRR NIH HHS
Zitieren
APA
Adjei-Sowah, E., Chandrasiri, I., Xiao, B., Liu, Y., Ackerman, J. E., Soto, C., Nichols, A. E. C., Nolan, K., Benoit, D. S. W., & Loiselle, A. E. (2024). Development of a nanoparticle-based tendon-targeting drug delivery system to pharmacologically modulate tendon healing. Science Advances. https://doi.org/10.1126/sciadv.adn2332
Vancouver
Adjei-Sowah E, Chandrasiri I, Xiao B, Liu Y, Ackerman JE, Soto C, et al. Development of a nanoparticle-based tendon-targeting drug delivery system to pharmacologically modulate tendon healing. Science Advances. 2024. doi:10.1126/sciadv.adn2332
BibTeX
@article{AdjeiSowah2024,
author = {Adjei-Sowah, Emmanuela and Chandrasiri, Indika and Xiao, Baixue and Liu, Yuxuan and Ackerman, Jessica E and Soto, Celia and Nichols, Anne E C and Nolan, Katherine and Benoit, Danielle S W and Loiselle, Alayna E},
title = {Development of a nanoparticle-based tendon-targeting drug delivery system to pharmacologically modulate tendon healing},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adn2332}
}
EUVIMED